Xofigo 1,100 KBQ/ML vials
Ended Awarded Last action
- Contract number
- SPE2DR26FMEB0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,468
Award facts
- Contract value 100% obligated
- $15,467.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,467.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of XOFIGO 1,100 KBQ/ML vials. The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of December 30, 2025. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare operations.
DMS Pharmaceutical Group was awarded the single-award IDC under PPV-G GEN V on November 13, 2025, with a ceiling value of $499,999,999 and completion through December 31, 2036. The prime vendor contract authorizes DLA to issue delivery orders for a comprehensive range of pharmaceuticals, including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. The company's selection as a regional prime vendor contractor reflects its demonstrated capability to fulfill specialized pharmaceutical requirements across multiple therapeutic categories for federal military medical operations.
Quick answers
Who was awarded contract SPE2DR26FMEB0?
SPE2DR26FMEB0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FMEB0 worth?
The government has obligated $15,468 on SPE2DR26FMEB0.
Is contract SPE2DR26FMEB0 an order under another contract?
Yes. SPE2DR26FMEB0 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEB0 competed?
The extent of competition for SPE2DR26FMEB0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award